CCL2 and Bartsocas-Papas syndrome 1: It has previously been demonstrated that moderate increases in the expression of MCP-1 mRNA in bladder tissues of patients with IC/BPS were directly correlated with the severity of clinical symptoms [26], providing evidence for the role of MCP-1 in the development of the disease process.